MarketInOut Stock Screener Log In | Sign Up

Symbiotec Pharmalab Limited

Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 15:57
Symbiotec Pharmalab Limited stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
Market Capitalization79,022 mln
Float45.07 mln
Earnings Date11/05/2026

EPS

14.63
Stretched

P / E

87.13
Speculative

1-Year Forecast

1,540.00
Attractive

Relative Strength

96 / 100
Top performer

Debt / Equity

0.34
Low leverage

Pre-Tax Margin

18%
Healthy margin

Business Description

Founded in 1995 and headquartered in Indore, India, Symbiotec Pharma Lab specializes in producing and selling active pharmaceutical ingredients, with particular expertise in corticosteroids, steroid hormones, and related compounds supplied to customers worldwide. The company also manufactures ingredients used across a broad range of treatment areas, including heart disease, pain relief, digestive conditions, skin disorders, and infections in children. In addition to its core product range, Symbiotec offers manufacturing and development services to other pharmaceutical businesses, supported by dedicated research and quality control facilities.

Key Fundamentals

EPS14.63
P/E87.13
ROE11.19
RPS141
ROIC8.43
ROA6.54
Interest Cover7.29
EBITDA, mln2,065
EV / EBITDA31.86
EV / EBIT41.36
Revenue, mln7,364
EV / Revenue8.51

Quote Details

Last 1,274.70
Change -3.1 (-0.24%)
Open 1,285.90
Volume 350,418
Turnover 446,677,792
Average Volume 1,113,516

Financial Ratios

Pre-Tax Profit Margin18
Current Ratio0.92
Price / Book6.12
Price / Tangible Book6.26
Debt / Equity0.34
Price / Sales8.10

Financial Strength

Price to Graham Number4.15
1-Year Target Price1,540.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.49% 92 / 100   
1 Month 27.04% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog